RHUMBLINE ADVISERS - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,096,607
+31.4%
63,133
+6.5%
0.00%0.0%
Q2 2023$834,408
+168127.4%
59,262
+28.6%
0.00%0.0%
Q1 2023$496
-25.4%
46,091
+3.8%
0.00%0.0%
Q4 2022$665
-99.9%
44,410
+3.3%
0.00%0.0%
Q3 2022$552,000
+42.3%
42,983
+7.3%
0.00%0.0%
Q2 2022$388,000
+10.2%
40,044
+13.1%
0.00%
Q1 2022$352,000
-13.7%
35,394
+2.1%
0.00%
-100.0%
Q4 2021$408,000
+1.0%
34,657
-2.3%
0.00%0.0%
Q3 2021$404,000
-20.5%
35,469
-2.7%
0.00%0.0%
Q2 2021$508,000
-4.5%
36,437
+26.7%
0.00%0.0%
Q1 2021$532,000
-0.9%
28,762
-5.4%
0.00%0.0%
Q4 2020$537,000
+36.3%
30,417
+18.3%
0.00%0.0%
Q3 2020$394,000
-33.6%
25,706
+10.4%
0.00%0.0%
Q2 2020$593,000
+126.3%
23,282
+37.7%
0.00%0.0%
Q1 2020$262,000
+40.1%
16,907
+0.3%
0.00%
Q4 2019$187,000
+32.6%
16,863
+2.0%
0.00%
Q3 2019$141,000
-37.1%
16,528
-0.2%
0.00%
Q2 2019$224,000
-3.0%
16,566
+29.3%
0.00%
Q1 2019$231,000
+3.6%
12,811
+61.2%
0.00%
Q4 2018$223,0007,9490.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders